Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Flat illustration of a CAR T-cell silhouette

May 18, 2026

Advanced startups wow Techweek audience across biotech and AI

The opening day of Techweek showcased innovative advancements in AI and biotechnology, emphasizing New Zealand's growing role in these sectors.During the conference, BioOra's CEO John Robson shared a compelling case involving a young girl with acute leukemia, whose treatment journey highlighted the evolution of cancer therapies. Despite traditional chemotherapy failing, she was treated with CAR T-cell therapy, a groundbreaking approach that led to her remission. BioOra is now on the verge of com
A prescription pad and pill bottle on a desk in a dimly lit office

May 18, 2026

Claritas Rx Expands Leadership Team as Specialty Pharma Turns to AI-Driven Patient Access Platforms

Claritas Rx is enhancing its leadership team to better address the evolving needs of specialty pharmaceuticals, particularly through AI-driven patient access solutions.The company has appointed Keith Pensabene as chief revenue officer and promoted Meghna Misra and Shelly Howard to vice president roles. These changes aim to bolster revenue growth and operational efficiency, aligning with the increasing investment in technology platforms that facilitate patient onboarding, reimbursement navigation
An illustration of an open patient health record with data extraction lines.

May 18, 2026

AI Partnership Unlocks Clinical Secrets in Patient Health Records

A new partnership between Lighten Platforms and Datavant aims to enhance clinical research by leveraging AI to extract valuable insights from unstructured patient health records.This collaboration seeks to address a significant challenge in medical research: accessing the vast information embedded in unstructured clinical notes. By integrating Lighten's AI-driven data curation into Datavant's analytics platform, the alliance aims to transform complex patient data into regulatory-grade evidence t
A minimalist illustration of a cloud and data stream representing AI in life sciences.

May 18, 2026

Anthill Cloud - an AI-Powered Content Excellence Platform for the US Life Sciences Market

Anthill has launched Anthill Cloud™, an innovative platform designed to enhance content creation and engagement in the US life sciences sector, particularly for pharmaceutical and biotech companies.The Anthill Cloud™ platform integrates generative AI, modular content authoring, and HCP (Healthcare Professional) engagement into a single, compliant ecosystem. This strategic tool addresses the growing complexity faced by US life science teams, such as the demand for personalized communications, the
A genomic sample on a lab bench with imaging equipment in the background.

May 18, 2026

MedGenome to expand integrated diagnostics access across Mumbai suburbs

MedGenome has announced a strategic collaboration with Siddhi Diagnostics & Research Centre (SDRC) to enhance access to integrated diagnostics in the suburban areas of Mumbai. This partnership aims to combine genomics with advanced imaging technologies, thereby improving precision diagnostics in regions that traditionally lack such resources.MedGenome, known for its focus on genomics-driven diagnostics, is poised to strengthen its presence in the Mumbai suburbs through this collaboration. SDRC,
Minimalist illustration of a drug package

May 18, 2026

Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization

Annora Pharma has intensified its partnership with AltiusHub to implement an AI-driven serialization platform aimed at enhancing operational efficiency and regulatory compliance in its global supply chain.The collaboration seeks to boost serialization efficiency by 45%, facilitating better tracking and compliance across major export markets, including the US, EU, GCC, LATAM, and ASEAN. Annora Pharma aims to achieve full real-time visibility of its serialized drug products within three months, en
A neuron and a surgical scalpel in flat design

May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has forged a landmark partnership with Time Medical International Ventures (India) Pvt. Ltd, marking a pivotal step in enhancing global neurosurgical care.This collaboration is notable as it is the first formal engagement between the WFNS Innovation Committee and an industry partner. The focus will be on pioneering neurosurgical technologies, advanced medical imaging, and global training initiatives aimed at
A skin sample on a glass slide in a clinical lab setting.

May 18, 2026

The Bull Case For Krystal Biotech (KRYS) Could Change Following UK Vyjuvek Approval And Rising Profitability

Krystal Biotech recently achieved a significant milestone with the UK approval of its gene therapy, Vyjuvek, for dystrophic epidermolysis bullosa. Coupled with a reported net income of approximately US$55.93 million in Q1 2026, this development enhances the company's standing in the rare disease sector.The recent approval allows Krystal Biotech to expand its market presence, potentially driving growth and diversifying its revenue streams. However, the company remains largely dependent on Vyjuvek
A flat design of a serialized product with a barcode on a solid background.

May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma has intensified its partnership with AltiusHub to enhance drug traceability globally through an AI-driven platform.The collaboration focuses on deploying AltiusHub’s advanced serialization and track-and-trace technology across Annora Pharma’s export operations. This initiative is projected to boost serialization efficiency by as much as 45% and improve visibility throughout the supply chain, particularly in key markets such as the US, EU, GCC, LATAM, and ASEAN regions. Annora Pharm
A flat illustration of a semiconductor chip with circuit patterns.

May 18, 2026

From AI to Semiconductors: Modi Courts Europe Inc. for India’s Next Growth Phase

Indian Prime Minister Narendra Modi has unveiled a comprehensive strategy aimed at enhancing industrial collaboration with Europe, focusing on five key sectors. The roadmap includes telecom and digital infrastructure, semiconductor and deep-tech manufacturing, clean energy, aerospace and logistics, as well as healthcare and life sciences. Modi emphasized the importance of the recently finalized India-EU Free Trade Agreement, referring to it as the "Mother of all Deals." This agreement is seen as
A medical chart and pen on an emergency room desk in low light.

May 18, 2026

Mayo Clinic Deploys AI-Powered ‘Ambient Listening’ in Emergency Room Visits

Mayo Clinic is implementing AI-driven "ambient listening" technology to enhance documentation during emergency room visits, raising important questions about consent and data privacy.The Mayo Clinic has introduced an AI-powered system that records and processes conversations between patients and healthcare providers in emergency settings. This technology aims to automate the documentation process, generating medical notes from recorded interactions. Notably, the system operates on an opt-out bas
A minimalist illustration of a pharmaceutical vial representing counterfeit drugs.

May 18, 2026

India’s counterfeit drug crisis and the role of AI

India is grappling with a significant rise in counterfeit high-value medications, including cancer therapies and weight-loss injections, which poses serious risks to patient safety. These counterfeit operations are not mere quality lapses but organized criminal activities that exploit weaknesses in the healthcare supply chain.Recent investigations reveal that counterfeiters are capitalizing on gaps in hospital waste disposal and supply chains. For instance, authentic vials of Merck's Keytruda ha